Clinical Trials - November 1, 2022
Gesynta Pharma prepares Phase II study of GS-248 in endometriosis
Gesynta Pharma has announced the decision to advance the development of its clinical-stage drug candidate GS-248 in endometriosis. This strategically important decision follows a recent preclinical proof-of-concept study with GS-248 in an advanced model of endometriosis, where disease-modifying properties of the drug candidate were firmly established, states the company in a press release. These data […]
Column - October 31, 2022
Commentary: Pandemic Preparedness
Staffan Svärd, Professor, Scientific Lead for SciLifeLab’s Pandemic Laboratory Preparedness Capability, writes about how lessons learned from the COVID-19 pandemic can increase our pandemic preparedness. Early in the pandemic, SciLifeLab, together with Knut and Alice Wallenberg Foundation, launched a major national COVID-19 research program. Today SciLifeLab has a government mandate to coordinate and expand the […]
Uncategorized - October 26, 2022
New Swedish Parkinson’s Disease clinical study approved
An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Authority, and the team, led from Lund University is thereby ready to proceed with the trial, they state. […]
Uncategorized - October 14, 2022
Strengthening Swedish collaboration in precision medicine
Genomic Medicine Sweden, GMS, has entered into an agreement with the Swedish life science sector’s trade associations to promote industry collaboration. The aim is to jointly strengthen national conditions for precision medicine. “For GMS, this agreement is a step towards creating improved and strengthened conditions for collaboration with industry. Through structured work, we will become […]
Uncategorized - October 14, 2022
A royal visit to SciLifeLab
SciLifeLab has welcomed their Majesties from the Netherlands and Sweden to learn more about technologies to study cells and initiatives for precision medicine. “It is a major recognition for SciLifeLab to be selected as a site for this state visit and it was our pleasure to guide these distinguished visitors through a glimpse of the […]
Uncategorized - September 28, 2022
New gene panel for solid tumors implemented in routine healthcare
Genomic Medicine Sweden (GMS) has developed a broad gene panel for solid tumors that facilitates detailed diagnostics for current and next generation targeted therapies. The new gene panel will be implemented in routine healthcare during the autumn. GMS’ working group for solid tumors has developed a gene panel that generates detailed molecular information from 560 […]